RxDoctor Payments Data

Adam Strantz

Physician Assistant · Fremont, MINPI 1316220437

Payments from drug & device makers

$2,930in general payments, 2019–2025

Across 167 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$742
  • Supernus Pharmaceuticals, Inc.$369
  • Teva Pharmaceuticals USA, Inc.$273
  • AbbVie$255
  • Johnson & Johnson$217
  • Lundbeck LLC$197
  • plus $876 from 15 others

What the payments were for

  • Food & beverage$2,67991%
  • Education$2529%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,930 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate16$57,179
RexultiBrexpiprazole24$36,436
TrintellixVortioxetine Hydrobromide15$10,688
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine52$2,981
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine43$715
Clonazepam95$705
Divalproex Sodium ErDivalproex Sodium11$688
Bupropion XlBupropion Hcl28$474
Lurasidone Hcl19$419
Venlafaxine Hcl ErVenlafaxine Hcl13$371
Duloxetine Hcl12$335
Trazodone Hcl12$316
Methylphenidate Hcl17$315
Buspirone Hcl23$307
Oxcarbazepine11$269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$217$57,17916 claims
Otsuka America Pharmaceutical, Inc.Rexulti$136$36,43624 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$88$10,68815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Fremont

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →